Your Client Rank:
Loading...
99
Updated 24-May-2022
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Daiichi | 12.2% | 1.4% | 0.3% | -7.3% | 22.6% | 5.1% | 35.5% | 35.9% |
| Novo | 11.1% | 0.2% | -2.1% | 0.8% | 1.3% | -0.2% | 14.1% | 15.8% |
| Lilly | 10.0% | 0.9% | -3.6% | -5.3% | 8.4% | 1.1% | 19.1% | 20.0% |
| Vertex | 7.2% | 0.3% | 0.9% | -0.9% | 0.2% | 0.1% | 8.0% | 8.0% |
| Astra | 7.0% | 0.6% | -3.4% | -1.3% | 5.7% | 0.1% | 13.1% | 13.5% |
| Lundbeck | 6.1% | 0.9% | -3.5% | -5.5% | 14.6% | 0.2% | 18.0% | 18.0% |
| Astellas | 6.0% | 0.4% | -3.0% | -0.5% | 7.2% | -0.3% | 12.6% | 13.9% |
| Sanofi | 5.4% | 0.9% | -3.0% | -1.8% | 4.3% | 0.7% | 7.7% | 7.8% |
| Eisai | 4.9% | 0.7% | 0.8% | -5.5% | 9.7% | -2.3% | 15.3% | 15.3% |
| Glaxo | 4.8% | 1.0% | -1.6% | 0.1% | 4.3% | 1.9% | 9.1% | 8.5% |
| Roche | 4.4% | 0.7% | -1.1% | -0.2% | 1.8% | -0.2% | 6.9% | 7.2% |
| Merck | 3.0% | 1.8% | -0.7% | -0.6% | 3.8% | 0.9% | 7.1% | 8.3% |
| Amgen | 2.6% | -0.1% | -0.9% | 0.2% | 0.1% | 0.2% | 4.1% | 6.0% |
| Shionogi | 2.4% | -0.1% | -0.3% | -2.8% | 3.8% | 4.2% | 3.0% | 3.8% |
| Novartis | 2.0% | 0.2% | -1.2% | -0.5% | 1.8% | -0.2% | 4.3% | 5.8% |
| JnJ | 2.0% | 0.1% | -0.5% | -0.8% | 2.1% | 0.9% | 3.9% | 4.7% |
| Teva | 1.9% | 0.4% | -0.5% | -1.2% | 1.5% | -0.4% | 5.8% | 5.2% |
| Bayer | 1.7% | 0.1% | -2.1% | 0.9% | 0.9% | 0.7% | 3.7% | 3.6% |
| Regeneron | 1.1% | -0.3% | -1.2% | 0.7% | -1.7% | 0.4% | 1.2% | 0.9% |
| Bristol | 1.1% | -0.7% | 0.3% | -0.1% | -0.6% | 0.2% | 0.5% | 2.6% |
| AbbVie | 0.8% | -0.5% | 0.4% | 1.8% | -1.5% | 4.0% | -0.7% | -0.3% |
| Gilead | 0.6% | -0.1% | 0.3% | 0.0% | -0.5% | 0.3% | 0.9% | 1.4% |
| Viatris | -0.5% | 0.3% | -2.0% | 7.7% | -0.7% | 0.1% | 0.5% | 0.4% |
| Chugai | -0.7% | 3.3% | 2.5% | 3.6% | 4.4% | 0.2% | 2.5% | 2.5% |
| Biogen | -0.9% | 1.4% | -0.2% | -0.5% | 2.7% | 0.9% | 0.7% | 3.5% |
| Takeda | -1.3% | -0.6% | 0.0% | 1.9% | 3.7% | -3.6% | 5.6% | 4.8% |
| Pfizer | -11.4% | 3.4% | 11.5% | 11.9% | -1.9% | 0.2% | -12.1% | -11.8% |
| EU Major | 4.7% | 0.7% | -2.1% | -0.4% | 3.2% | 0.5% | 8.2% | 8.1% |
| Other EU | 6.1% | 0.9% | -3.5% | -5.5% | 14.6% | 0.2% | 18.0% | 18.0% |
| US Major | -0.5% | 1.1% | 2.0% | 2.0% | 0.6% | 0.8% | 0.3% | 5.0% |
| US Big Biotech | 1.9% | 0.1% | -0.7% | 0.0% | 0.1% | 0.3% | 3.0% | 3.4% |
| Other US | 0.6% | 0.3% | -1.2% | 2.9% | 0.2% | -0.1% | 2.8% | 2.6% |
| Japanese | 2.9% | 0.7% | 0.7% | -0.7% | 6.3% | -0.3% | 9.6% | 8.3% |
